Atlas Trials

Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer

Clinical trial NCT01264328 · COMPLETED

Trial details

NCT number
NCT01264328
Sponsor
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2011-03-09
Primary completion
2011-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.